Foglé-Hansson M, Rundcrantz H
Acta Otolaryngol Suppl. 1979;360:33-4. doi: 10.3109/00016487809123464.
Thirty patients with allergic rhinoconjunctivitis were treated with eye drops containing 2% DSCG during the pollen season of 1977. Sixteen patients were treated with active substance and 14 with placebo. The results show a statistically significant difference in favour of the DSCG drops. DSCG in eye drops seems to be a valuable complement to the drugs available today for the treatment of allergic rhinoconjunctivitis.
1977年花粉季节期间,30例变应性鼻结膜炎患者接受了含2%色甘酸钠(DSCG)的滴眼液治疗。16例患者接受活性药物治疗,14例接受安慰剂治疗。结果显示,色甘酸钠滴眼液具有统计学上的显著优势。滴眼液中的色甘酸钠似乎是目前治疗变应性鼻结膜炎药物的一种有价值的补充。